Schizophrenia patients report reduced pain sensitivity in clinical studies, but experimental studies are required to establish pain sensitivity as a potential endophenotype. We conducted a systematic review of electronic databases from database inception until 15/04/2015, including experimental studies investigating pain among schizophrenia-spectrum disorder patients versus healthy controls.A random effect meta-analysis yielding Hedges' g ±95% confidence intervals (CIs) as the effect size measure (ES) was conducted. Primary outcome was a pooled composite of pain threshold, pain tolerance, and sensory threshold; secondary outcomes included these parameters individually, plus physiological pain response, and pain intensity/unpleasantness. Across 17 studies, schizophreniaspectrum disorder patients (n=387, age=30.7±6.9 years, female=31.9%, illness duration=7.0±5.7 years) were compared with controls (n=483, age=29.5±7.4 years, female=31.0%). Patients had elevated pain threshold/pain tolerance/sensory threshold versus controls (ES=0.493, 95% CI=0.145-0.839, p=0.005; studies=17). Results were similar in antipsychotic-free individuals (ES=0.599, 95% CI=0.291-0.907, p<0.0001; studies=8), with trend-level significance in antipsychotic-treated individuals (ES=0.428, p=0.085; studies=11 spectrum disorders. How this alteration links to other dimensions of schizophrenia and physical comorbidity-related help-seeking behaviour/morbidity/mortality requires further study. schizophrenia, pain, experimental pain, physical health, pain assessment, pain management 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 Dr. Correll has been a consultant and/or advisor to or has received honoraria from AbbVie, Actavis, Alkermes, Bristol-Myers Squibb, Eli Lilly, Genentech, Gerson Lehrman Group, IntraCellular Therapies, Janssen/J&J, Lundbeck, MedAvante, Medscape, Otsuka, Pfizer, ProPhase, Reviva, Roche, Sunovion , 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 3 Abstract Schizophrenia patients report reduced pain sensitivity in clinical studies, but experimental studies are required to establish pain sensitivity as a potential endophenotype. We conducted a systematic review of electronic databases from database inception until 15/04/2015, including experimental studies investigating pain among schizophrenia-spectrum disorder patients versus healthy controls.
Key words:A random effect meta-analys...